Oncocyte Corp
- CIK: 0001642380
- EIN: 27-1041563
- Business address: 15 CUSHING, IRVINE, California, 92618
Information
Mailing address
15 CUSHING, IRVINE, California, 92618Phone
949-409-7600State location
CaliforniaState of incorporation
CaliforniaFiscal year end
December 31SIC
2835 - (CF Office: Office of Life Sciences) IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCESFilings
N/A
About Oncocyte Corp
Oncocyte Corp (CIK: 0001642380) is an American company incorporated in the state of California. Head office is located at 15 CUSHING, IRVINE, California, 92618. Work in the industry 2835 - (CF Office: Office of Life Sciences) IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES. Oncocyte Corp is a public company and trade via Over-The-Counter (OTC).Ownership
| Owner | Filings | Transaction Date | Type of Owner |
|---|---|---|---|
| Gutfreund John Peter | 0001940797 | Jun-30-2023 | other: Former Director |
| Riggs Josh | 0001956391 | Dec-02-2022 | officer: Interim CEO |
| SILVERMAN LOU | 0001249935 | Nov-30-2022 | director |
| Liu James Yang | 0001944774 | Sep-20-2022 | officer: Controller, PAO |
| John Anish M. | 0001933248 | Jun-01-2022 | officer: SVP, Finance, and Interim CFO |
| PURA VIDA INVESTMENTS, LLC | 0001590144 | Apr-14-2022 | 10 percent owner |
| Kamen Efrem | 0001789193 | Apr-14-2022 | 10 percent owner |
| Paulsen Gisela | 0001807104 | Oct-04-2021 | officer: Chief Operating Officer |
| Yu Li | 0001777275 | May-18-2021 | officer: VP Cntrllr/Prncpl Acctng Offcr |
| Carter Jennifer L. | 0001806505 | Aug-24-2020 | director |
| Ross Douglas T. | 0001808413 | Mar-23-2020 | officer: Chief Medical Officer |
| KALAJIAN TONY T | 0001786237 | Aug-09-2019 | officer: SVP-Chief Accounting Officer |
| GRIFFITH MELINDA | 0001783697 | Jul-17-2019 | director |
| Sundar Padma | 0001778709 | May-22-2019 | officer: SVP, Marketing & Market Access |
| ANDREWS RONALD ASBURY | 0001299153 | Aug-30-2018 | director |
| Parker Albert P | 0001750079 | Aug-06-2018 | officer: Chief Operating Officer |
| Levine Mitchell S | 0001383492 | Nov-15-2017 | officer: Chief Financial Officer |
| HESTERBERG LYNDAL K. | 0001689836 | Nov-01-2016 | officer: Sr VP, Research & Development |
| BAILEY DON M | 0001223697 | Aug-29-2016 | director |
| BROADWOOD PARTNERS LP | 0001278386 | Aug-29-2016 | 10 percent owner |
| BROADWOOD CAPITAL INC | 0001278387 | Aug-29-2016 | 10 percent owner |
| BRADSHER NEAL C | 0001278388 | Aug-29-2016 | 10 percent owner |
| BIOTIME INC | 0000876343 | Dec-30-2015 | 10 percent owner |
| SEGALL JUDITH | 0001054745 | Dec-30-2015 | officer: Corporate Secretary |
| KARFUNKEL GEORGE | 0001085765 | Dec-30-2015 | 10 percent owner |
| WEST MICHAEL D | 0001202529 | Dec-30-2015 | director |
| KINGSLEY ALFRED D | 0001229339 | Dec-30-2015 | director |
| SKIBSTED RUSSELL | 0001308105 | Dec-30-2015 | officer: Chief Financial Officer |
| Redmond Cavan M. | 0001420120 | Dec-30-2015 | director |
| Arno Andrew | 0001472122 | Dec-30-2015 | director |
| Last Andrew J. | 0001485088 | Dec-30-2015 | director |
| MOHANTY ADITYA P. | 0001629819 | Dec-30-2015 | director |
| MECHEM KRISTINE C. | 0001662454 | Dec-30-2015 | officer: VP of Marketing |
| CHAPMAN KAREN B. | 0001662550 | Dec-30-2015 | officer: Vice President of Research |
| ANNETT WILLIAM | 0001662553 | Dec-30-2015 | director, officer: President and CEO |
Stock Chart
Coming soon!
Jobs
Coming soon!
Recent SEC Filings
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Oncocyte Corp
| Filings | Format | Description | Filed/Effective | File/Film Number |
|---|---|---|---|---|
| 8-K | Document | Current report filing Acc-no: 0001493152-25-016685 (34 Act) Size: KB |
Oct-02-2025 | 251368936 |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001493152-25-016360 ( Act) Size: 0 KB |
Sep-30-2025 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001493152-25-016349 ( Act) Size: 0 KB |
Sep-30-2025 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001493152-25-016291 ( Act) Size: 0 KB |
Sep-30-2025 | |
| 8-K | Document | Current report filing Acc-no: 0001493152-25-014240 (34 Act) Size: KB |
Sep-19-2025 | 251326877 |
| S-8 | Document | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans Acc-no: 0001641172-25-024607 (33 Act) Size: KB |
Aug-18-2025 | 251227950 |
| 10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000950170-25-106552 (34 Act) Size: KB |
Aug-11-2025 | 251202113 |
| 8-K | Document | Current report filing Acc-no: 0001641172-25-022974 (34 Act) Size: KB |
Aug-11-2025 | 251202084 |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001641172-25-017796 ( Act) Size: 0 KB |
Jul-03-2025 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001641172-25-017798 ( Act) Size: 0 KB |
Jul-03-2025 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001641172-25-017787 ( Act) Size: 0 KB |
Jul-03-2025 | |
| 8-K | Document | Current report filing Acc-no: 0001641172-25-017590 (34 Act) Size: KB |
Jul-02-2025 | 251102309 |
| 8-K | Document | Current report filing Acc-no: 0001641172-25-015338 (34 Act) Size: KB |
Jun-17-2025 | 251051831 |
| ARS | Document | Annual report to security holders Acc-no: 0001641172-25-010398 (34 Act) Size: KB |
May-14-2025 | 25947270 |
| DEFA14A | Document | Additional definitive proxy solicitation materials Acc-no: 0001641172-25-010369 (34 Act) Size: KB |
May-14-2025 | 25946984 |
| DEF 14A | Document | Definitive proxy statements Acc-no: 0001641172-25-010366 (34 Act) Size: KB |
May-14-2025 | 25946973 |
| 10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000950170-25-069213 (34 Act) Size: KB |
May-12-2025 | 25934944 |
| 8-K | Document | Current report filing Acc-no: 0001641172-25-009681 (34 Act) Size: KB |
May-12-2025 | 25934891 |
| SCHEDULE 13G/A | Document | Acc-no: 0001535264-25-000041 (34 Act) Size: KB | May-09-2025 | 25930404 |
| 8-K | Document | Current report filing Acc-no: 0001641172-25-005288 (34 Act) Size: KB |
Apr-17-2025 | 25848374 |
Recent 20 filings. View all Oncocyte Corp filings
Reviews
Pelisari
young lad who new his job ansered questions and new what was best for me.
Samuel Ejimofor
It's being easier working on the website. And I recommend, it's a great website
Jean Bishop
Very good communication and delivery made within the timeframe I was advised of
Frequently Asked Questions
Tags:
- Oncocyte Corp overview
- Oncocyte Corp job
- Oncocyte Corp stock
- Oncocyte Corp ownership
- Oncocyte Corp CEO
- Oncocyte Corp documents
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
Orther Companies
Anbio Biotechnology
Update: Jan 01, 2025
Asep Medical Holdings Inc.
Update: May 30, 2024
ZYMETX INC
Update: Aug 26, 2022
ZyCare, Inc.
Update: Aug 26, 2022
WORLDWIDE MEDICAL CORP/CA/
Update: Aug 25, 2022
WILLS GERARD A
Update: Aug 25, 2022
Latest News
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Charges Crypto Company SafeMoon and its Executive Team for...
© 2022 